Why Did Progressive Stock Go Down?
Shares of insurance giant Progressive (NYSE:PGR) have fallen considerably over…
Sell
45
CE Quote, Financials, Valuation and Earnings
Last price:
$59.47
Seasonality move
:
11.07%
Day range:
$55.73 - $57.98
52-week range:
$45.94 - $172.16
Dividend yield:
3.73%
P/E ratio:
7.03x
P/S ratio:
0.61x
P/B ratio:
1.21x
Volume:
27.6M
Avg. volume:
4.6M
1-year change:
-66.08%
Market cap:
$6.2B
Revenue:
$10.3B
EPS (TTM):
-$13.93
Analysts' Opinion
-
Consensus RatingCelanese has received a consensus rating of Hold. The company's average rating is a Hold based on 5 Buy ratings, 9 Hold ratings, and 2 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $64.16, Celanese has an estimated upside of 12.36% from its current price of $57.10.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $46.00 representing 19.44% downside risk from its current price of $57.10.
Fair Value
-
According to the consensus of 16 analysts, Celanese has 12.36% upside to fair value with a price target of $64.16 per share.
CE vs. S&P 500
-
Over the past 5 trading days, Celanese has underperformed the S&P 500 by -0.42% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Celanese does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Celanese revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Celanese reported revenues of $2.4B.
Earnings Growth
-
Celanese earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Celanese reported earnings per share of -$17.50.
Enterprise value:
18.3B
EV / Invested capital:
1.01x
Price / LTM sales:
0.61x
EV / EBIT:
15.02x
EV / Revenue:
1.78x
PEG ratio (5yr expected):
0.14x
EV / Free cash flow:
34.45x
Price / Operating cash flow:
11.77x
Enterprise value / EBITDA:
36.37x
Gross Profit (TTM):
$2.4B
Return On Assets:
-5.98%
Net Income Margin (TTM):
-14.81%
Return On Equity:
-21.13%
Return On Invested Capital:
-7.48%
Operating Margin:
8.69%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $9.7B | $10.9B | $10.3B | $2.6B | $2.4B | |
| Gross Profit | $2.4B | $2.6B | $2.4B | $613M | $539M | |
| Operating Income | $1.4B | $1.2B | $1B | $269M | $206M | |
| EBITDA | $2.3B | $2.6B | $503M | $505M | -$1.2B | |
| Diluted EPS | $17.36 | $17.90 | -$13.93 | $6.37 | -$17.50 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.8B | $3.8B | $6.6B | $6.2B | $5.1B | |
| Total Assets | $10.9B | $12B | $26.3B | $26.6B | $22.9B | |
| Current Liabilities | $2B | $2.5B | $4.1B | $4.1B | $3.9B | |
| Total Liabilities | $7B | $7.4B | $20.2B | $19B | $17.2B | |
| Total Equity | $3.9B | $4.5B | $6.1B | $7.6B | $5.6B | |
| Total Debt | $3.7B | $4B | $14.7B | $13.7B | $12.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.8B | $1.9B | $966M | $830M | $494M | |
| Cash From Investing | -$11.1B | -$134M | -$470M | -$168M | -$128M | |
| Cash From Financing | $10.3B | -$1.5B | -$1.3B | -$240M | -$189M | |
| Free Cash Flow | $1.3B | $1.3B | $531M | $702M | $389M | |
CE
Sector
Market Cap
$6.2B
$18.5M
Price % of 52-Week High
33.17%
62.21%
Dividend Yield
3.73%
0%
Shareholder Yield
--
1.29%
1-Year Price Total Return
-66.08%
-11.3%
Beta (5-Year)
1.227
1.012
Dividend yield:
3.73%
Annualized payout:
$2.80
Payout ratio:
-20.17%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$56.32
200-day SMA
Sell
Level
$103.48
Bollinger Bands (100)
Sell
Level
53.81 - 92.01
Chaikin Money Flow
Buy
Level
106.5M
20-day SMA
Buy
Level
$53.96
Relative Strength Index (RSI14)
Sell
Level
48.82
ADX Line
Sell
Level
22.32
Williams %R
Sell
Level
-17.5166
50-day SMA
Sell
Level
$63.11
MACD (12, 26)
Sell
Level
-1.60
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
194.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.4145)
Sell
CA Score
(Annual)
Level (-1.5175)
Buy
Beneish M-Score
(Annual)
Level (-3.1126)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-0.1246)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
Stock Forecast FAQ
In the current month, CE has received 5 Buy ratings 9 Hold ratings, and 2 Sell ratings. The CE average analyst price target in the past 3 months is $64.16.
-
Where Will Celanese Stock Be In 1 Year?
According to analysts, the consensus estimate is that Celanese share price will rise to $64.16 per share over the next 12 months.
-
What Do Analysts Say About Celanese?
Analysts are divided on their view about Celanese share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Celanese is a Sell and believe this share price will drop from its current level to $46.00.
-
What Is Celanese's Price Target?
The price target for Celanese over the next 1-year time period is forecast to be $64.16 according to 16 Wall Street analysts, 5 of them rate the stock a Buy, 2 rate the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is CE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Celanese is a Hold. 9 of 16 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CE?
You can purchase shares of Celanese via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Celanese shares.
-
What Is The Celanese Share Price Today?
Celanese was last trading at $59.47 per share. This represents the most recent stock quote for Celanese. Yesterday, Celanese closed at $57.10 per share.
-
How To Buy Celanese Stock Online?
In order to purchase Celanese stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did StoneCo Stock Go Up So Much?
Brazilian fintech company StoneCo (NASDAQ:STNE) has been on a tear…
Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 24
Regencell Bioscience Holdings [RGC] is down 28.36% over the past day.
Buy
54
TNXP alert for Mar 24
Tonix Pharmaceuticals Holding [TNXP] is up 32.39% over the past day.
Sell
36
VMI alert for Mar 24
Valmont Industries [VMI] is up 4.67% over the past day.
